; or (2) create an additional review of scientific protocols that is only conducted for research on marijuana other than the review of research protocols performed at the request of a researcher conducting nonhuman research that is not federally funded, in accordance with section 303(f)(3)(A)(ii)(II) of the Controlled Substances Act ( 21 U.S.C. 823(f)(3)(A)(ii)(II) ), as amended by subsection (d). (g) Consideration of results of research Immediately upon the approval by the Food and Drug Administration of an application for a marijuana-based drug under section 505 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355 ), and (irrespective of whether any such approval is granted) not later than the date that is 5 years after the date of enactment of this Act, the Secretary shall— (1) conduct a review of existing medical and other research with respect to marijuana; (2) submit a report to the Congress on the results of such review